secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2023-12-11T23:59:59+00:00
Accession:  0001104659-23-124995
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents raises gross $10.3M in registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Offers 7.73M shares plus warrants for 2.71M shares at $2.00 exercise price; combined price $1.33 per unit.
- Gross proceeds $10.29M; net ~$9.83M after expenses; closing expected Dec 12, 2023.
- Insiders (executives, directors, employees) purchase 327,070 shares and 114,465 warrants.
- Proceeds to fund DrugSorb-ATR marketing efforts, clinical studies, R&D, and working capital.
- Company states net proceeds plus existing cash fund operations into Q3 2024; seeks additional non-dilutive capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923124995/0001104659-23-124995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923124995/tm2332399d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-124995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer